Ramipril Prevents Endothelial Dysfunction Induced by Oxidized Low-Density Lipoproteins:A Bradykinin-Dependent Mechanism

Hypertension

Volumn 30, Issue 3, 1997, Pages 371-376

  Berkenboom, Guy ^a   Langer, Ingrid ^a   Carpentier, Yvon ^a   Grosfils, Katrina ^a   Fontaine, Jeanine ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ARGININE; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIMYCIN; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; LOSARTAN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RAMIPRIL;

ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; BRADYKININ; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; LIPOPROTEINS, LDL; LOSARTAN; MALE; NITRIC OXIDE; RAMIPRIL; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; VASODILATION;

EID: 0030863655     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.371     Document Type: Article

References (36)

1. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest. 1993;91:1453-1458.
2. Becker RHA, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol. 1991;18(suppl 2):S110-S115.
3. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Waegovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation. 1996;94:258-265.
4. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
5. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of SHR-derived cultured smooth muscle cells is dependent on autocrine production of TGF-B. Circ Res. 1992;70:820-828.
6. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
7. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol. 1993;22(suppl 9):S1-S8.
8. Wiemer G, Scholkens BA, Linz W. Endothelial protection by converting enzyme inhibitors. Cardiovasc Res. 1994;28:166-172.
9. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
10. Linz W, Wiemer G, Scholkens BA. ACE inhibition induces NO formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol. 1992;24:909-919.
11. Zanzinger J, Zheng X, Bassenge E. Endothelium-dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin-dependent mechanism. Cardiovasc Res. 1994;28:209-214.
12. Berkenboom G, Brekine D, Unger P, Grosfils K, Staroukine M, Fontaine J. Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta. Hypertension. 1995;26:738-743.
13. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987;84:2995-2998.
14. Tanner FC, Noll G, Boulanger CM, Luscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991;83:2012-2020.
15. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
16. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
18. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984;81:3883-3887.
19. Pohl U, Busse R. Endothelium-derived relaxant factor inhibits the effect of nitrocompounds in isolated arteries. Am J Physiol. 1987;252:H307-H313.
20. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
21. Levy JV. Prostacyclin-induced contraction of isolated aortic strip from normal and spontaneously hypertensive rats (SHR). Prostaglandins. 1980;19:517-521.
22. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides. J Biol Chem. 1972;247:1106-1113.
23. Andrew HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987;327:237-239.
24. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333-337.
25. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J Supramol Struct. 1980;13:67-81.
26. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
27. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
28. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
29. Bossaller C, Auch-Schwelk W, Weber F, Gotze S, Grafe M, Graf K, Fleck E. Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin converting enzyme inhibitor enalapril. J Cardiovasc Pharmacol. 1992;20(suppl 9):S91-S95.
30. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.
31. Hecker M, Dambacher T, Busse R. Role of endothelium-derived bradykinin in the control of vascular tone. J Cardiovasc Pharmacol. 1992;20(suppl 9):S55-S61.
32. Dusting GJ, Hyland R, Hickey H, Makdissi M. Angiotensin converting enzyme inhibitors reduce neointimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am J Cardiol. 1995;76:24E-27E.
33. Holtz J, Goetz RM. Vascular renin-angiotensin-system, endothelial function and atherosclerosis? Basic Res Cardiol. 1994;89(suppl 1):71-86.
34. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
35. Mombouli JV, Illiano S, Nagao T, Vanhoutte PM. The potentiation of bradykinin-induced relaxations by perindoprilat in canine coronary arteries involves both nitric oxide and endothelium-derived hyperpolarizing factor. Circ Res. 1992;71:137-144.
36. omega -nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery. Circulation. 1995;92:3520-3526.